Here's the live share price of Coral Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Coral Laboratories has gained 6.05% CAGR. Over the past year, the corresponding return has been -39.61%.
Coral Laboratories’s current P/E of 9.93x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Coral Laboratories | 2.53 | -3.59 | -14.61 | -26.66 | -39.61 | 24.21 | 6.05 |
| Sun Pharmaceutical Industries | 0.33 | 2.35 | 3.15 | -7.76 | -6.42 | 17.65 | 27.40 |
| Divi's Laboratories | 6.12 | 17.18 | 5.13 | 11.31 | 15.80 | 22.16 | 16.40 |
| Cipla | -4.08 | -0.53 | -0.64 | -2.42 | -4.97 | 9.52 | 14.02 |
| Torrent Pharmaceuticals | -0.10 | 1.39 | -1.07 | 8.86 | 11.75 | 28.91 | 22.42 |
| Dr. Reddy's Laboratories | -6.95 | -3.82 | -2.01 | 2.41 | -5.30 | 9.89 | 4.00 |
| Zydus Lifesciences | -2.85 | -2.16 | 1.37 | 9.05 | -3.13 | 30.30 | 17.26 |
| Mankind Pharma | -1.47 | -3.37 | -9.86 | -1.93 | -13.37 | 18.50 | 10.72 |
| Lupin | 4.01 | 3.10 | 6.12 | -4.27 | -8.71 | 41.14 | 16.17 |
| Alkem Laboratories | 4.30 | 3.20 | 15.47 | 11.61 | -2.26 | 20.29 | 16.02 |
| Aurobindo Pharma | 4.77 | 5.10 | 5.60 | -7.30 | -18.14 | 27.67 | 8.06 |
| Abbott India | -1.34 | -2.12 | -13.63 | -4.47 | -0.20 | 14.70 | 13.16 |
| Laurus Labs | 2.36 | 13.77 | 14.00 | 58.86 | 101.49 | 28.34 | 28.79 |
| Glenmark Pharmaceuticals | 1.69 | -6.33 | -10.97 | 31.35 | 8.61 | 63.66 | 29.98 |
| Biocon | 3.92 | 9.50 | -0.58 | 13.22 | 22.27 | 11.53 | -1.52 |
| GlaxoSmithKline Pharmaceuticals | 0.21 | -2.66 | -7.06 | -7.98 | 1.93 | 25.53 | 13.79 |
| Anthem Biosciences | -1.49 | -8.06 | -6.71 | -3.81 | -3.81 | -1.29 | -0.77 |
| Ipca Laboratories | 0.77 | -2.12 | -10.29 | -6.88 | -18.52 | 12.62 | 1.79 |
| Ajanta Pharma | 8.79 | 6.76 | -1.59 | 0.20 | -13.37 | 27.38 | 19.28 |
| Gland Pharma | 0.17 | -1.74 | -3.80 | 34.33 | 18.38 | 1.73 | 0.92 |
Over the last one year, Coral Laboratories has declined 39.61% compared to peers like Sun Pharmaceutical Industries (-6.42%), Divi's Laboratories (15.80%), Cipla (-4.97%). From a 5 year perspective, Coral Laboratories has underperformed peers relative to Sun Pharmaceutical Industries (27.40%) and Divi's Laboratories (16.40%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 500.47 | 500.42 |
| 10 | 498.98 | 501.23 |
| 20 | 508.42 | 504.16 |
| 50 | 503.47 | 515.88 |
| 100 | 542.08 | 549.02 |
| 200 | 633.5 | 597.49 |
In the latest quarter, Coral Laboratories remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding moved down to 28.49% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
|---|---|
| Oct 13, 2025, 10:04 PM IST | Coral Labs. - Outcome Of The Board Meeting Held On October 13, 2025 For Capacity Expansion At The Plant Located At Dehradun " |
| Oct 13, 2025, 9:22 PM IST | Coral Labs. - Intimation Regarding Capacity Addition Under Regulation 30 (Read With Part A Of Schedule III) Of The Securities |
| Oct 13, 2025, 9:07 PM IST | Coral Labs. - Board Meeting Outcome for Outcome Of The Board Meeting Held On October 13, 2025 For Capacity Expansion At The P |
| Oct 09, 2025, 8:23 PM IST | Coral Labs. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Sep 27, 2025, 12:25 AM IST | Coral Labs. - Combined Scrutinizer Report For Remote E-Voting And Voting At The AGM Carried Out For The 43Rd Annual General M |
Coral Laboratories Ltd. is a Public Limited Listed company incorporated on 06/02/1997 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24231MH1997PLC422233 and registration number is 422233. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 115.01 Cr. and Equity Capital is Rs. 3.57 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Coral Laboratories is ₹498.00 as on Nov 04, 2025.
The Coral Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Coral Laboratories is ₹177.92 Cr as on Nov 04, 2025.
Today’s highest and lowest price of Coral Laboratories are ₹499.00 and ₹487.50.
The 52-week high/low is the highest and lowest price at which Coral Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Coral Laboratories is ₹896.00 and 52-week low of Coral Laboratories is ₹442.55 as on Nov 04, 2025.
The Coral Laboratories has shown returns of 0.64% over the past day, -3.59% for the past month, -14.61% over 3 months, -39.61% over 1 year, 24.21% across 3 years, and 6.05% over 5 years.
P/E ratio of and PB ratio of Coral Laboratories are 9.93 and 0.87 on Nov 04, 2025. While the company gives a dividend yield of 0.30 per annum.